Company · VEON
VEON Ltd.
Nasdaq's symbol directory lists VEON on Nasdaq as “VEON Ltd. - American Depositary Shares”: an American depositary receipt, a certificate traded in the US for shares of a foreign company.
In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($1.1M); 4 filings by holders of 5% or more.
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Fabela Augie K II bought $1.1M
Every trade (2)
- BUYFabela Augie K II bought $280K
- BUYFabela Augie K II bought $840K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Shah Capital Management 6.72%
- Shah Capital Management 6.72%
- LPE Middle East Limited 45.46%
- Giovanni Agnelli B.V. 7.12%
Lobbying · Senate LDA reports
Lobbying filed
3 quarterly lobbying reports for 2026 naming VEON Ltd. as the client: 3 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- AKIN GUMP STRAUSS HAUER & FELD no amount stated
- AKIN GUMP STRAUSS HAUER & FELD no amount stated
- AKIN GUMP STRAUSS HAUER & FELD no amount stated
Sources: SEC EDGAR (Forms 4 and 144), Senate LDA lobbying reports and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.